Compare 14 telehealth providers offering semaglutide and tirzepatide in Washington. Independent pricing, verified reviews, no sponsored rankings.
Ranked by our editorial score — price, transparency, clinical rigor, and patient satisfaction.
Telehealth platform specializing in affordable compounded GLP-1 medications for weight loss. Known for aggressive pricing on compounded semaglutide and tirzepatide with fast onboarding.
Major telehealth platform offering GLP-1 weight loss programs with compounded and brand-name semaglutide and tirzepatide. Known for accessible pricing and a streamlined digital experience.
Weight-care platform combining GLP-1 medications with behavior change coaching, nutrition guidance, and community support. Takes a holistic approach beyond medication alone.
Publicly traded (NYSE: HIMS) telehealth company offering GLP-1 weight loss treatments alongside men's and women's health services. Offers both compounded and brand-name GLP-1 options.
Telehealth marketplace connecting patients with licensed doctors for peptide therapy, hormone optimization, and wellness prescriptions. Competitive pricing through network model.
Metabolic health company offering a comprehensive one-year GLP-1 weight loss program that combines medication with metabolic reset through food, sleep, exercise, and emotional health coaching.
Men's health telehealth platform offering hormone optimization and peptide therapy with at-home lab testing and physician-guided treatment plans.
Large-scale telehealth platform (publicly traded) offering weight management via GLP-1 medications alongside dermatology, hair loss, and primary care services.
Integrated telehealth platform with primary care and specialized peptide/weight-loss programs. Appeals to users wanting peptide therapy within a broader healthcare relationship.
FORM Health is a physician-led obesity medicine practice delivered entirely via telehealth. Unlike platforms that added GLP-1 prescribing to an existing product (Noom, Hims, Ro), FORM was built from the ground up as an obesity medicine specialty practice. Every FORM clinician is a board-certified physician specializing in obesity medicine — not general practitioners doing questionnaire reviews. This clinical depth comes at a premium price point, but delivers a level of medical sophistication tha
Noom started as a behavior-change app focused on psychology-driven weight loss coaching, built around cognitive behavioral therapy (CBT) principles. In 2023, they launched Noom Med, adding GLP-1 prescriptions to their platform. This makes Noom one of the few providers that combines medication with a structured behavioral curriculum — an approach that could help address the weight regain problem associated with GLP-1 discontinuation. The coaching program predates the medication offering by over a
PlushCare is a broad-spectrum telehealth platform offering primary care, mental health, dermatology, and weight management — not a weight-loss-specific company. Acquired by Accolade (publicly traded health services company) in 2021, PlushCare brings the backing of an established healthcare organization. Their generalist model means GLP-1 prescriptions happen within a broader healthcare relationship, and they work extensively with insurance rather than pushing cash-pay compounded medications.
Sequence positions itself as the "clinical-first" GLP-1 telehealth provider. Founded by obesity medicine specialists, the platform emphasizes board-certified clinicians, insurance-first prescribing, and a medically rigorous approach compared to most direct-to-consumer competitors. Their model prioritizes getting patients onto brand-name FDA-approved medications through insurance rather than defaulting to compounded alternatives.
Sesame takes a radically different approach to telehealth GLP-1 access: no subscriptions, no memberships, no monthly fees. You pay per visit, get a prescription if appropriate, and fill it wherever you want. Think of Sesame as the à la carte option — stripped-down, transparent pricing with no ongoing commitments. This model gives patients maximum flexibility but shifts the work of finding affordable medication to the patient.
Monthly semaglutide and tirzepatide pricing across providers serving the Washington-Arlington-Alexandria area.
| Provider | Price | Type | Notes |
|---|---|---|---|
Henry MedsBest price | $149/monthly | Subscription | Compounded semaglutide |
| $149/monthly | Subscription | Compounded semaglutide; brand Wegovy also available | |
| $159/monthly | Subscription | Compounded semaglutide; brand options available at higher cost | |
| $199/monthly | Subscription | Compounded semaglutide | |
| $275/monthly | One-time | Consultation fee separate | |
| $299/monthly | Subscription | Includes 1:1 coaching, labs, and video visits; medication cost separate if not covered by insurance | |
| $299/monthly | Subscription | — | |
| $299/monthly | Subscription | — | |
| $350/monthly | Subscription | May be covered by employer health plan |
| Provider | Price | Type | Notes |
|---|---|---|---|
CalibrateBest price | $299/monthly | Subscription | Same program fee; medication cost varies by insurance |
| $349/monthly | Subscription | Compounded tirzepatide | |
| $375/monthly | One-time | Consultation fee separate | |
| $399/monthly | Subscription | Brand Zepbound | |
| $399/monthly | Subscription | Brand tirzepatide | |
| $399/monthly | Subscription | Brand Zepbound available | |
| $399/monthly | Subscription | — | |
| $399/monthly | Subscription | — | |
| $450/monthly | Subscription | May be covered by employer health plan |
Prices reflect telehealth platform costs as of March 2026.See our methodology.
Washington DC's high cost of living is balanced by strong federal employee health benefits and a competitive telehealth market. Many DC residents access GLP-1 treatment through employer-sponsored programs.
Maryland has comprehensive telehealth regulations permitting prescribing via telehealth. The state requires providers to be licensed in Maryland and follow the same standard of care as in-person visits.
Washington DC has its own telehealth regulations separate from Maryland and Virginia. DC permits telehealth prescribing of GLP-1 medications, and the District's regulations are generally telehealth-friendly.
Local note: DC's large federal workforce has access to FEHB plans, many of which are expanding weight management and GLP-1 coverage.
In-Person Visit Required?
No
Compounding Restrictions?
Yes
Async Telehealth Allowed?
Yes
Telehealth Parity Law?
Yes
Regulations as of 2026. Telehealth laws change frequently. Always verify current requirements with your provider.
Answer 5 quick questions and we'll match you with the best GLP-1 provider available in Washington, DC.
Take the 2-Minute QuizYes. DC residents can access most major telehealth GLP-1 providers. The District permits remote prescribing and has a strong telehealth infrastructure.
Many Federal Employees Health Benefits (FEHB) plans cover weight management services, including some GLP-1 medications. Coverage varies by plan, so check your specific FEHB plan details.
Telehealth providers must be licensed in the state where the patient is located. If you live in Virginia or Maryland, you need a provider licensed in your state, not DC. Most national platforms serve all three jurisdictions.
Telehealth Ally is an independent comparison platform. Our rankings are never influenced by compensation. Provider availability, pricing, and regulations are researched and verified by our editorial team. State telehealth regulations change frequently — always confirm current requirements with your chosen provider. This page is not medical advice.
We track prices so you don't have to.
No spam. Unsubscribe anytime.